Howard Lovy

Articles by Howard Lovy

Calif. official: Lower AIDS drug prices

California State Controller John Chiang is pushing forward aggressively with a campaign to get drugmakers to lower the price of the AIDS medication Atripla, according to a report by Ed Silverman on

Supreme Court: County can't sue for alleged drug overcharging

The U.S. Supreme Court has ruled that only the federal government has a right to enforce its rules against overcharging for prescription drugs in public-health facilities and that the parties

Conflicts of interest uncomfortably common in cardiology

To some extent, conflicts of interest are unavoidable among those who write and review clinical practice guidelines. After all, if you're qualified to review guidelines, odds are you probably work in

More evidence links Lipitor with diabetes

While researchers have already linked the cholesterol drug Lipitor (atorvastatin) with a higher risk of type 2 diabetes, a new study "strengthens evidence of a connection," according to a Reuters

Novartis CEO: iPad saves time, keeps reps honest

The iPad is being promoted by Novartis CEO Joe Jimenez as a technological miracle drug that will allow sales reps to pitch to tens of thousands customers each year, save hundreds of hours, keep them

Gout medicine Colcrys' pricing under scrutiny

Slate wades in on recent drug-pricing news, and accompanying outrage among some in the media and in Congress, with an update on the gout medicine colchicine. Like February's news involving KV

Drug prices rise faster than other medical expenses

Put all your prescription drugs in a basket and compare their prices over the past four years with the price of other medical goods and services. According to the U.S. Government Accountability

Australian pharma industry blasts budget plan

From your personal checkbook to your nation's budget, everybody is trying to keep the books balanced these days. In Australia, they've decided to cut back on pharmaceutical subsidies. No new

Report: Pfizer's found 10 companies for closed UK site

Back in February, Pfizer announced it would shutter its Sandwich UK R&D facility, which employs 2,400 people. Now, the BBC is reporting the drug giant has found some companies that would like to

Portrait of an Indian Pharma acquisition 'failure'

The Wall Street Journal features a little case study in what can go wrong three years after an acquisition that was once billed as a match made in pharmaceutical heaven. Back in June 2008,